Videos

Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center

Videos

Cryoablation For Breast Cancer: Efficacy and Techniques

10/03/2024

Yolanda Bryce , MD, RPVI;

At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.

At the 2024 CIO Meeting, Yolanda...

10/03/2024

IO Learning

Conference Coverage

Darolutamide Demonstrates Efficacy and Safety for Metastatic Hormone-Sensitive Prostate Cancer

10/02/2024

Fred Saad , MD;

Fred Saad, MD, discusses results from the phase 3 ARANOTE trial which assessed the efficacy and tolerability of adding darolutamide to androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.

Fred Saad, MD, discusses results...

10/02/2024

Oncology

Conference Coverage

Neoadjuvant Immune Checkpoint Inhibitors Extend Survival Among Patients With Advanced Melanoma

10/01/2024

Georgina Long, MD, PhD, discusses updated pooled analysis results from the International Neoadjuvant Melanoma Consortium which identified that neoadjuvant immunotherapy extends survival in patients with advanced melanoma.

Georgina Long, MD, PhD,...

10/01/2024

Oncology

Videos

WOUNDS Journal Welcomes New Submissions and Contributors

10/01/2024

In this video, John C. Lantis II, MD, Editor-in-Chief, and Vickie Driver, DPM, Clinical Editor, welcome new submissions and contributors to work with Wounds Journal. Interested in getting involved with the Journal? Contact the Wounds...

In this video, John C. Lantis...

10/01/2024

Wounds

Videos

Best Practices for Prescribing Long-Acting Injectable Medications Via Telehealth

09/30/2024

Desiree Matthews , PHMNP-BC;

Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.

Desiree Matthews, PMHNP-BC, CEO,...

09/30/2024

Psych Congress Network

Videos

Survival Trends Among Patients With Metastatic NSCLC Before and After the Approval of Immunotherapy in the US

09/27/2024

Yating Wang , MD;

Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.

Yating Wang, MD, shares the...

09/27/2024

Journal of Clinical Pathways

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

Journal of Clinical Pathways

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Demetria Smith-Graziani, MD, MPH, Winship Cancer Institute

Videos

Inavolisib vs Alpelisib Plus Fulvestrant For Patients With PIK3CA-Mutated Advanced Breast Cancer

09/24/2024

Demetria J. Smith-Graziani , MD, MPH;

Demetria Smith-Graziani, MD, MPH, describes the currently enrolling and ongoing INAVO121 trial, evaluating inavolisib vs alpelisib, both in combination with fulvestrant, for patients with PIK3CA-mutated, hormone receptor-positive,...

Demetria Smith-Graziani, MD,...

09/24/2024

Oncology